1.Volberding, PA et al. (2004) Anemia in HIV infection: clinical impact and evidence-based management strategies. Clinical Infectious Diseases 38, 1454–1463.
2.Semba, RD (2003) Iron-deficiency anemia and the cycle of poverty among human immunodeficiency virus-infected women in the inner city. Clinical Infectious Diseases 37(Suppl. 2), S105–S111.
3.Sullivan, PS et al. (1998) Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 91, 301–308.
4.Moore, RD (2000) Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy. Seminars in Hematology 37, 18–23.
5.Belperio, PS and Rhew, DC (2004) Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. American Journal of Medicine 116(Suppl. 7A), 27s–43s.
6.Parinitha, S and Kulkarni, M (2012) Haematological changes in HIV infection with correlation to CD4 cell count. The Australasian Medical Journal 5, 157–162.
7.Assefa, M et al. (2015) Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. BMC Hematology 15, 6.
8.Akilimali, PZ et al. (2015) Predictors of persistent anaemia in the first year of antiretroviral therapy: a retrospective cohort study from Goma, the Democratic Republic of Congo. PLoS ONE 10, e0140240.
9.Tesfaye, Z and Enawgaw, B (2014) Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study. BMC Research Notes 7, 745.
10.Santiago-Rodriguez, EJ et al. (2014) Anemia in a cohort of HIV-infected Hispanics: prevalence, associated factors and impact on one-year mortality. BMC Research Notes 7, 439.
11.Dai, G et al. (2017) Anemia in combined antiretroviral treatment-naive HIV-infected patients in China: a retrospective study of prevalence, risk factors, and mortality. Bioscience Trends 10, 445–453.
12.Shen, Y et al. (2013) Prevalence of anemia among adults with newly diagnosed HIV/AIDS in China. PLoS ONE 8, e73807.
13.Mijiti, P et al. (2015) Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China. International Journal of STD & AIDS 26, 156–164.
15.Denue, BA et al. (2013) Prevalence of anemia and immunological markers in HIV-infected patients on highly active antiretroviral therapy in northeastern Nigeria. Infection Diseases 6, 25–33.
16.Adane, A et al. (2012) HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia. Ethiopian Medical Journal 50, 13–21.
17.Wisaksana, R et al. (2011) Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia. BMC Infectious Diseases 11, 213.
18.Kyeyune, R et al. (2014) Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda. BMC Infectious Diseases 14, 496.
19.Gedefaw, L et al. (2013) Anemia and risk factors in HAART naive and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS ONE 8, e72202.
20.Melese, H et al. (2017) Anemia among adult HIV patients in Ethiopia: a hospital-based cross-sectional study. HIV AIDS (Auckl) 9, 25–30.
21.Owiredu, WK et al. (2011) Prevalence of anaemia and immunological markers among Ghanaian HAART-naive HIV-patients and those on HAART. African Health Sciences 11, 2–15.
22.Meidani, M et al. (2012) Prevalence, severity, and related factors of anemia in HIV/AIDS patients. Journal of Research in Medical Sciences 17, 138–142.
23.Moyle, G (2002) Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Reviews 4, 13–20.
24.Mugisha, JO et al. (2008) Anaemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Tropical Medicine and International Health 13, 788–794.
25.Bunupuradah, T et al. (2013) Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy. International Journal of Infectious Diseases 17, e806–e810.
26.Wills, TS et al. (2004) Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort. The AIDS Reader 14, 305–310, 313–305.
27.Dikshit, B et al. (2009) Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disorders 9, 5.
28.Mata-Marin, JA et al. (2010) Risk factors and correlates for anemia in HIV treatment-naive infected patients: a cross-sectional analytical study. BMC Research Notes 3, 230.
29.Mert, A et al. (2017) Miliary tuberculosis: epidemiological and clinical analysis of large-case series from moderate to low tuberculosis endemic Country. Medicine (Baltimore) 96, e5875.
30.McDermid, JM et al. (2013) Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study. BMC Infectious Diseases 13, 48.
31.Subbaraman, R et al. (2009) Factors associated with anaemia in HIV-infected individuals in southern India. International Journal of STD and AIDS 20, 489–492.
32.Qiu, Y et al. (2015) Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesions. BMC Infectious Diseases 15, 47.
33.Li, HR et al. (2016) Comparison of Talaromyces marneffei infection in human immunodeficiency virus-positive and human immunodeficiency virus-negative patients from Fujian, China. Chinese Medical Journal (Engl.) 129, 1059–1065.
34.Liechty, CA et al. (2007) Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Tropical Medicine and International Health 12, 929–935.